Lobaplatin is a third-generation platinum-based antineoplastic agent belonging to the oxaliplatin class, commonly utilized in chemotherapy regimens for treating various solid tumors, including breast cancer,… Read more











Lobaplatin is a third-generation platinum-based antineoplastic agent belonging to the oxaliplatin class, commonly utilized in chemotherapy regimens for treating various solid tumors, including breast cancer, chronic myeloid leukemia, and small-cell lung cancer. As a cytotoxic drug, it functions by inhibiting DNA replication through intercalation and cross-linking mechanisms, effectively inducing apoptosis in rapidly dividing cancer cells. This category provides high-quality reference standards, analytical impurities, and related derivatives essential for the rigorous quality control and impurity profiling of this pharmaceutical compound. Pharmaceutical laboratories rely on these characterized materials during method development and validation to ensure the potency, stability, and purity of drug formulations. By using these certified reference standards and identified process-related impurities, researchers can accurately monitor safety profiles and meet regulatory requirements throughout the drug development lifecycle.